Memorial Symptom Assessment Scale

References

• Silvestri G, Pritchard R, Welch HG. Preferences for chemotherapy in patients with advanced nonsmall cell lung cancer: descriptive study based on scripted interviews. BE Med 317,771–775 (1998).
   PubMed Web of Science ®Google Scholar
• Brodman K, Erdmann AJ, Lorge I et al The Cornell Medical Index, an adjunct to the medical interview. 14/11A 140,530–534 (1949).
   Google Scholar
• Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. j Palliat. Care 7,6–9 (1991).
   Google Scholar
• McCorlde R, Young K. Development of a symptom distress scale. Cancer NUTS. 1, 373–378 (1978).
   Google Scholar
• Hollen PJ, Grail RJ,Kris MG et al. Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the Lung Cancer Symptom Scale. Cancer 73,2087–2098 (1994).
   Google Scholar
• De Haes JCJM, van Knippenburg FCE, Nejit JR Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. BE j Cancer 62, 1034–1038 (1990).
   Google Scholar
• Cleeland CS, Mendoza TR, Wang XS et al. Assessing symptom distress in cancer patients: the MD Anderson Symptom Inventory. Cancer 89,1634–1646 (2000).
   PubMed Web of Science ®Google Scholar
• Portenoy RK,Thaler HT, Kornblith AB et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics, and distress. Eur.j Cancer 30A, 1326–1336 (1994).
   Google Scholar
• Fishman B, Pasternak S, Wallenstein S, Houde R, Holland JC, Foley KM. The Memorial Pain Assessment Card: a valid instrument for the assessment of cancer pain. Cancer60, 1151–1157 (1987).
   PubMedGoogle Scholar
• Ware JE, Johnston SA, Davies-Avery A et al. Conceptualization and measurement of health for adults. In: The Health Insurance Study Volume VIII Rand, CA, USA (1979).
   Google Scholar
• Schipper H, Clinch J, McMurray A, Levitt M. Measuring the quality of life of cancer patients: The Functional Living Index-Cancer. Development and validation. Clin. Oncol 2,472–483 (1984).
   PubMed Web of Science ®Google Scholar
• Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: Evaluation of Chemotherapeutic Agents. Macleod CM (Ed.). Columbia University Press, NY, USA, 191–205 (1949).
   Google Scholar
• Cella DF, Tulsky DS, Gray G et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. j Clin. Oncol 11, 570–579 (1993).
   PubMed Web of Science ®Google Scholar
• Chang VT, Hwang S, Feuerman M, Kasimis B. Symptom and Quality of life survey of medical oncology patients at a veterans affairs medical center. A role for symptom assessment. Cancer 88, 1175–1183 (2000).
   Google Scholar
• Seidman AD, Portenoy RK, Yao TJ et al. Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony stimulating factor. j Natl Cancer Inst. 87,1316–1322 (1995).
   PubMed Web of Science ®Google Scholar
• Brady MJ, Cella DF, Mo F et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. j Clin. Oncol 15,974–986 (1997).
   PubMed Web of Science ®Google Scholar
• Modi S, Panageas KS, Duck ET et al Prospective exploratory analysis of the association between tumor response, quality of life, and expenditures amont patients receiving paclitaxel monotherapy for refractory metastatic breast cancer. Clin. Oncol 20,3665–3673 (2002).
   Google Scholar
• Du Pen SL, Du Pen AR, Polissar N et al Implementing guidelines for cancer pain management: results of a randomized controlled clinical trial. j Clin. Oncol 17, 361–370 (1999).
   PubMed Web of Science ®Google Scholar
• Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psycho" Med. 12,595-605 (1983).
   Google Scholar
• Beck AT Depression: clinical, experimental and theoretical aspects. Harper and Row, NY, USA (1967).
   Google Scholar
• Vogl D, Rosenfeld B, Breitbart W et al. Symptoms prevalence, characteristics, and distress in AIDS outpatients. j Pain Symptom Manage. 18,253–262
   Google Scholar
• Selwyn PA, Rivard M, Kappell D et al. Palliative care for AIDS at a large urban teaching hospital: program description and preliminary outcomes. j Palliative Med. 6, 461–474 (1999).
   Google Scholar
• Chang VT, Hwang SS, Feuerman M, Kasimis B. Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center. Cancer 88, 1175–1183 (2000).
   PubMed Web of Science ®Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. Natl Cancer Inst. 85,365–376 (1993).
   Google Scholar
• Stromgren AS, Groenvold M, Pedersen L, Olsen AK, Sjogren P Symptomatology of cancer patients in palliative care: content validation of self-assessment questionnaires against medical records. Eur. j Cancer 38, 788–794 (2002).
   PubMedGoogle Scholar
• Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM. The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nuts. Forum 25,677–684 (1998).
   PubMedGoogle Scholar
• Tranmer JE, Heyland D, Dudgeon D, Groll D, Squires-Graham M, Coulson K. Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the Memorial Symptom Assessment Scale. J. Pain Symptom Manage. 25, 420–429 (2003).
   Google Scholar
• ••Data from a large sample of patients withcontrasts of symptoms in patients with advanced cancer and with other advanced diseases.
   Google Scholar
• List M, Ritter-Sterr C, Lansky S. A performance status scale for head and neck cancer patients. Cancer66, 564–569 (1990).
   PubMed Web of Science ®Google Scholar
• Harrison LB, Zelefsky MJ, Pfister DG et al. Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Heacl Neck 19,169–175 (1997).
   PubMed Web of Science ®Google Scholar
• Collins JJ, Devine TD, Dick GS et al. The measurement of symptoms in young children with cancer: the validation of the Memorial Symptom Assessment Scale in children aged 7-12. J Pain Symptom NIanage. 23,10–16 (2002).
   PubMed Web of Science ®Google Scholar
• Breitbart W, McDonald MV, Rosenfeld B et al Pain in ambulatory AIDS patients. I. Pain characteristics and medical correlates. Pain 68,315–321 (1996).
   PubMed Web of Science ®Google Scholar
• Rosenfeld B, Breitbart W, McDonald MV, Passik SD, Thaler H, Portenoy RK. Pain in ambulatory AIDS patients. II. Impact of pain on psychological functioning and quality of life. Pain 68, 323–328 (1996).
   Google Scholar
• Payne R, Mathias SD, Pasta DJ, Wanke LA, Williams R, Mahmoud R. Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine.j Gun. Oncol 16,1588–1593 (1998).
   Google Scholar
• Breitbart W, McDonald MV, Rosenfeld B, Monkman ND, Passik SD. Fatigue in ambulatory AIDS patients. J. Pain Symptom Manage. 15,159–167 (1998).
   PubMed Web of Science ®Google Scholar
• Gift AG, Shephard CE. Fatigue and other symptoms in patients with chronic obstructive pulmonary disease: do women and men differ?" Obstet. Cynecol Neonatal Nuts. 28,201–208 (1999).
   PubMedGoogle Scholar
• Kornblith AB, Thaler HT, Wong G et al. Quality of life of women with ovarian cancer. Cynecol Oncol 59,231–42 (1995).
   PubMed Web of Science ®Google Scholar
• Portenoy RK, Thaler HT, Kornblith AB etal. Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res. 3,183–189 (1994).
   Google Scholar
• Hickman SE, Tilden VP, Tolle SW Family reports of dying patients' distress: the adaptation of a research tool to assess global symptom distress in the last week of life. J. Pain Symptom Manage. 22,565–574 (2001).
   PubMedGoogle Scholar
• Lobchuk MM. The Memorial Symptom Assessment Scale: modified for use in understanding family caregivers' perceptions of cancer patients' symptom experiences. J. Pain Symptom Manage. 26, 644–654 (2003).
   PubMedGoogle Scholar
• Lobchuk MM, Degner LE Symptom experiences: perceptual accuracy between advanced-stage cancer patients and family caregivers in the home care setting. J. Clin. Oncol 20,3495–3507 (2002).
   PubMed Web of Science ®Google Scholar
• Kutner JS, Kassner CT, Nowels DE. Symptom burden at the end of life: hospice providers' perceptions. J. Pain Symptom Manage. 21,473-480 (2001).
   Google Scholar
• Chang VT, Thaler HT, Polyak TA, Kornblith AB, Lepore JM, Portenoy RK. Quality of life and survival: the role of multidimensional symptom assessment. Cancer 83,173–179 (1998).
   PubMed Web of Science ®Google Scholar
• McClement S, Woodgate R, Degner L. Symptom distress in adult patients with cancer. Cancer NUTS. 20,236–243 (1997).
   Google Scholar
• Chang, VT The value of symptoms in prognosis of cancer patients. In: Topics in Palliative Care. Volume Four Bruera E, Portenoy RK (Eds). Oxford University Press, NY, USA, 23–54 (2000).
   Google Scholar
• Nelson CJ, Rosenfeld B, Brietbart W, Galietta M. Spirituality, religion and depression in the terminally ill. PFbosomatics 43,213–220 (2002).
   PubMed Web of Science ®Google Scholar
• Peterman AH, Fitchett G, Brady MJ, Hernandez L, Cella D. Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy—Spiritual Well-being Scale (FACIT-Sp). Ann. &hay. Merl 24,49–58 (2002).
   Google Scholar
• Broadhead WE, Gehlbach SH, De Gruy FV et al. The Duke UNC Functional Social Support Questionnaire: measurement of social support in family medicine patients. Merl Care 26,709–723 (1988).
   PubMed Web of Science ®Google Scholar
• Chang VT, Hwang SS, Feuerman M, Kasimis BS, Thaler HT The Memorial Symptom Assessment Scale Short Form (MSAS-SF). Cancer 89,1162–1171 (2000).
   PubMed Web of Science ®Google Scholar
• Hwang SS, Chang VT, Fairclough DL, Cogswell J, Kasimis B. Longitudinal quality of life in advanced cancer patients: pilot study results from a VA medical cancer center. J. Pain Symptom Manage. 25, 225–235 (2003).
   Google Scholar
• •• Illustrates how the Memorial Symptom Assessment Scale (MSAS) Short Form can be used to longitudinally follow patients with advanced cancer.
   Google Scholar
• Hwang SS, Chang VT Cogswell J, Kasimis BS. Clinical relevance of fatigue levels in cancer patients at a Veterans Administration Medical Center. Cancer94, 2481–2489 (2002).
   PubMed Web of Science ®Google Scholar
• Mendoza TR, Wang XS, Cleeland CS et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 85, 1186–1196 (1999).
   PubMed Web of Science ®Google Scholar
• Hwang SS, Chang VT, Kasimis BS. A comparison of three fatigue measures in veterans with cancer. Cancer Invest. 21, 363–373 (2003).
   Google Scholar
• Chang VT, Hwang SS, Kasimis B. Longitudinal documentation of cancer pain management outcomes: a pilot study at a VA medical center. J. Pain Symptom Manage. 24,494-505 (2002).
   Google Scholar
• Hwang SS, Scott CB, Chang VT etal. Prediction of survival for advanced cancer patients by recursive partitioning analysis. Cancer Invest. (In Press) (2004).
   Google Scholar
• Chang VT, Hwang SS, Kasimis BS, Thaler HT Shorter Symptom Assessment Instruments: The Condensed Memorial Symptom Assessment Scale (CMSAS). Cancer Invest. (2004) (In Press).
   Google Scholar
• •Illustrates how a symptom instrument can be shortened while preserving quality of life information.
   Google Scholar
• Osenenko P, Chang VT, Hwang SS et al Validation of a short simple symptom assessment instrument in terminally ill patients, the Condensed Memorial Symptom Assessment Scale (CMSAS). Proc. ASC0734, 2950 (2003).
   Google Scholar
• NIH State-of-the Science Panel. National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15–17 (2002). INCI95, 1110–1117 (2003).
   Google Scholar
• Chang V, Ingham J. Symptom control. Cancer Invest. 21,564–578 (2003).
   PubMed Web of Science ®Google Scholar
• Cleeland CS, Bennett GJ, Dantzer R etal. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 97, 2919–2925 (2003).
   Google Scholar
• Clohisy R, Mantyh P. Bone cancer pain. Cancer 97\(Suppl. 3), 866–873 (2003).
   Google Scholar
• Farrar JT, Portenoy RK, Berlin JA, Kinman J, Strom BL. Defining the clinically important difference in pain outcome measures. Pain 88,287–294 (2000).
   Google Scholar
• Farrar JT, Berlin JA, Strom BL. Clinically important changes in acute pain outcome measures: a validation study. j Pain Symptom. Manage. 25,406-411 (2003).
   Google Scholar
• Soni MK, Cella D, Masters GA, Burch SP, Heyes A, Silberman C. The validity and clinical utility of symptom monitoring in advanced lung cancer: a literature review. Clin. Lung Cancer 4, 153–160 (2002).
   PubMedGoogle Scholar
• Kelly K. The benefits of achieving stable disease in lung cancer. Oncology17, 957–963 (2003).
   PubMedGoogle Scholar
• Dodd MJ, Miaskowski C, Paul SM. Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nuts. Forum 28,465–470 (2001).
   Google Scholar
• Cleeland CS, Reyes-Gibby CC. When is it justified to treat symptoms? Measuring symptom burden. Oncology16(9 Suppl. 10), 64–70 (2002).
   Google Scholar
• Woodgate RL, Degner LF, Yanofsky R. A different perspective to approaching cancer symptoms in children. j Pain Symptom Manage. 26,800–817 (2003).
   PubMed Web of Science ®Google Scholar
• Detmar SB, Muller MJ, Schornagel JH, Weyer LD, Aaronson NK. Health-related quality-of-life assessments and patient—physician communication: a randomized controlled trial. JAMA 288, 3027–3034 (2002).
   PubMed Web of Science ®Google Scholar
• Johnson JR, Temple R. Food and Drug Administration requirements for approval of new anticancer drugs. Cancer Treat. Rep. 691155–1159 (1985).
   Google Scholar
• Dahl JL, Saeger L, Stein W, Huss RD. The new JCAHO pain assessment standards: implications for the medical director. jAm Med. Dir. Assoc. 1 (Suppl. 6), S24—S31
   Google Scholar
• Dahl JL. Working with regulators to improve the standard of care in pain management: the US experience. j Pain Symptom Manage. 24,136–146 (2002).
   PubMedGoogle Scholar
• Sloan JA, Cella D, Frost M et al Assessing clinical significance in measuring oncology patient quality of life: introduction to the symposium, content overview and definition of terms. Mayo Clin. Proc. 77, 367–370 (2000).
   Google Scholar
• ••Series of articles in the Mayo Clinic Proceedings discuss important issues in quality of life assessment that have direct relevance to symptom assessment.
   Google Scholar